These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 20415260)

  • 1. [Investigation of therapeutic and protective effect of Reaferon-ES Lipint on mice infected with avian influenza virus (subtype H5N1)].
    Demina OK; Sergeev AA; Agafonov AP; Shikov AN; Sementsova AO; Sergeev AA; Sergeev AN; Drozdov IG
    Antibiot Khimioter; 2009; 54(9-10):27-9. PubMed ID: 20415260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Triazavirin prophylactic efficacy against influenza virus A (H5N1)].
    Loginova SIa; Borisevich SV; Maksimov VA; Bondarev VP; Kotovskaia SK; Rusinov VL; Charushin VN; Chupakhin ON
    Antibiot Khimioter; 2010; 55(9-10):25-8. PubMed ID: 21400750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose interferon Type I treatment is effective against H5N1 and swine-origin H1N1 influenza A viruses in vitro and in vivo.
    Haasbach E; Droebner K; Vogel AB; Planz O
    J Interferon Cytokine Res; 2011 Jun; 31(6):515-25. PubMed ID: 21323570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of oral gavage treatment with ZnAL42 and other metallo-ion formulations on influenza A H5N1 and H1N1 virus infections in mice.
    Barnard DL; Wong MH; Bailey K; Day CW; Sidwell RW; Hickok SS; Hall TJ
    Antivir Chem Chemother; 2007; 18(3):125-32. PubMed ID: 17626596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy of combined administration of ridostin and oseltamivir (tamiflu) for therapy and prophylaxis of experimental infection induced by influenza virus A (H5N1) in mice].
    Skarnovich MO; Shishkina LN; Kabanov AS; Mazurkova NA; Danilenko ED; Masycheva VI; Drozdov IG
    Zh Mikrobiol Epidemiol Immunobiol; 2011; (5):79-82. PubMed ID: 22145356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virus-like particle vaccine comprised of the HA, NA, and M1 proteins of an avian isolated H5N1 influenza virus induces protective immunity against homologous and heterologous strains in mice.
    Tao P; Luo M; Zhu D; Qu S; Yang Z; Gao M; Guo D; Pan Z
    Viral Immunol; 2009 Jul; 22(4):273-81. PubMed ID: 19594398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prophylactic and therapeutic efficacies of Ingavirin, a novel Russian chemotherapeutic, with respect to influenza pathogen A (H5N1)].
    Loginova SIa; Borisevich SV; Shkliaeva OM; Maksimov VA; Bondarev VP; Nebol'sin VE
    Antibiot Khimioter; 2010; 55(7-8):10-2. PubMed ID: 21140557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic effects of chitin microparticles on highly pathogenic H5N1 influenza virus.
    Ichinohe T; Nagata N; Strong P; Tamura S; Takahashi H; Ninomiya A; Imai M; Odagiri T; Tashiro M; Sawa H; Chiba J; Kurata T; Sata T; Hasegawa H
    J Med Virol; 2007 Jun; 79(6):811-9. PubMed ID: 17457919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of reaferon and alpha-tocopherol on lipid peroxidation in experimental influenza].
    Pertseva NG; Ananenko AA; Malinovskaia VV; Klembovskiĭ AI; Burova VIa; Meshkova EN; Kleĭmenova NV
    Vopr Virusol; 1995; 40(2):59-62. PubMed ID: 7762231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral activity of the proteasome inhibitor VL-01 against influenza A viruses.
    Haasbach E; Pauli EK; Spranger R; Mitzner D; Schubert U; Kircheis R; Planz O
    Antiviral Res; 2011 Sep; 91(3):304-13. PubMed ID: 21777621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amantadine-oseltamivir combination therapy for H5N1 influenza virus infection in mice.
    Ilyushina NA; Hoffmann E; Salomon R; Webster RG; Govorkova EA
    Antivir Ther; 2007; 12(3):363-70. PubMed ID: 17591026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant modified vaccinia virus Ankara-based vaccine induces protective immunity in mice against infection with influenza virus H5N1.
    Kreijtz JH; Suezer Y; van Amerongen G; de Mutsert G; Schnierle BS; Wood JM; Kuiken T; Fouchier RA; Lower J; Osterhaus AD; Sutter G; Rimmelzwaan GF
    J Infect Dis; 2007 Jun; 195(11):1598-606. PubMed ID: 17471429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal attenuation of a PR8-derived mouse pathogenic H5N1 recombinant virus for testing antigenicity and protective efficacy in mice.
    Kim IH; Kwon HJ; Park JK; Song CS; Kim JH
    Vaccine; 2015 Nov; 33(46):6314-9. PubMed ID: 26428455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A subunit vaccine candidate derived from a classic H5N1 avian influenza virus in China protects fowls and BALB/c mice from lethal challenge.
    Liu G; Zhang F; Shi J; Tian G; Chen H; Yu K; Meng Q
    Vaccine; 2013 Nov; 31(46):5398-404. PubMed ID: 24055355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simvastatin and oseltamivir combination therapy does not improve the effectiveness of oseltamivir alone following highly pathogenic avian H5N1 influenza virus infection in mice.
    Belser JA; Szretter KJ; Katz JM; Tumpey TM
    Virology; 2013 Apr; 439(1):42-6. PubMed ID: 23453580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of recombinant human alpha interferon against influenza virus infection in mice.
    Sasaki O; Karaki T; Imanishi J
    Biken J; 1985 Dec; 28(3-4):79-82. PubMed ID: 3010939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections.
    Zou Z; Yan Y; Shu Y; Gao R; Sun Y; Li X; Ju X; Liang Z; Liu Q; Zhao Y; Guo F; Bai T; Han Z; Zhu J; Zhou H; Huang F; Li C; Lu H; Li N; Li D; Jin N; Penninger JM; Jiang C
    Nat Commun; 2014 May; 5():3594. PubMed ID: 24800825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic and therapeutic combination effects of rimantadine and oseltamivir against influenza virus A (H3N2) infection in mice.
    Simeonova L; Gegova G; Galabov AS
    Antiviral Res; 2012 Aug; 95(2):172-81. PubMed ID: 22617756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different infection routes of avian influenza A (H5N1) virus in mice.
    Sun R; Luo J; Gao Y; He H
    Integr Zool; 2009 Dec; 4(4):402-8. PubMed ID: 21392312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of inactivated vaccine against H5N1 influenza virus infection in mice with type 1 diabetes.
    Wu J; Zhang F; Fang F; Chang H; Wang F; Yang Z; Sun B; Chen Z
    Vaccine; 2010 Mar; 28(15):2775-81. PubMed ID: 20117261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.